A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder.

Completed · Phase 3

Conditions studied: Attention Deficit/Hyperactivity Disorder

In brief

To evaluate long-term safety exposure

Key facts

Study ID
NCT05279313
Run by
Otsuka Pharmaceutical Development & Commercialization, Inc.
People needed
680
Starts
2022-02-24
Expected to finish
2026-04-24
Last updated by the study team
2026-05-14

Who can join

Age: 4 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.